The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.
Piet Christiaens
Advertisement
Piet Christiaens is scientific director at Nelson Labs Europe.
Articles by Piet Christiaens
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
